Profile data is unavailable for this security.
Mergers & acquisitions
| Acquired company | LLY:NYQ since announced | Transaction value |
|---|---|---|
| Orna Therapeutics Inc | -1.72% | 2.40bn |
| Ventyx Biosciences Inc | -2.26% | 1.01bn |
| Adverum Biotechnologies Inc | 26.67% | 274.32m |
| Verve Therapeutics Inc | 28.78% | 1.25bn |
| SiteOne Therapeutics Inc | 45.72% | 1.00bn |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
